Compare CBUS & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CBUS | DLHC |
|---|---|---|
| Founded | 2010 | 1969 |
| Country | United States | United States |
| Employees | N/A | 2300 |
| Industry | Agricultural Chemicals | Business Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.5M | 87.4M |
| IPO Year | 2017 | 2012 |
| Metric | CBUS | DLHC |
|---|---|---|
| Price | $1.79 | $5.30 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 499.8K | 29.2K |
| Earning Date | 05-14-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.33 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,639,000.00 | ★ $41,923,000.00 |
| Revenue This Year | $112.72 | N/A |
| Revenue Next Year | $83.18 | $0.05 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.57 |
| 52 Week Low | $1.09 | $5.03 |
| 52 Week High | $4.19 | $8.09 |
| Indicator | CBUS | DLHC |
|---|---|---|
| Relative Strength Index (RSI) | 54.01 | 41.12 |
| Support Level | $1.31 | $5.08 |
| Resistance Level | $1.99 | $6.22 |
| Average True Range (ATR) | 0.24 | 0.18 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 37.23 | 14.52 |
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.